United States Healthcare Equipment & Supplies

Shoulder Innovations, Inc. (SI)

Track

Track

Shoulder Innovations experienced significant insider trading activity over the past ninety days, totaling seventeen sell transactions valued at approximately 10.6 million dollars. Key executives, including the CEO and COO, alongside Gilde Healthcare Holding, offloaded shares following the August earnings report. The stock price has declined 11.7 percent during this period, currently trading near its yearly low.
Ticker: SI Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Shoulder Innovations, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Ball Robert Joseph CEO & Executive Chairman Executive Director
Transaction date
Sale
Price
357.28
Quantity 3,751 +5.9%
Value US$4,400,490
2.2
ROBERT BALL Officer; Director Executive Director
Transaction date
Proposed sale
Price
494.84
Quantity 45,181
Value US$2,985,930
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
21.38
Quantity 1,600 -0.7%
Value US$34,211
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
20.94
Quantity 12,586 -4.9%
Value US$263,493
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
20.10
Quantity 8,314 -3.1%
Value US$167,101
MATTHEW AHEARN Director; Officer Executive Director
Transaction date
Proposed sale
Price
20.73
Quantity 22,500
Value US$466,425
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
19.26
Quantity 2,500 -0.9%
Value US$48,148
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
18.20
Quantity 1,644 -0.6%
Value US$29,922
Ahearn Matthew Fraser Chief Operating Officer Executive Director
Transaction date
Planned sale
Price
18.68
Quantity 15,856 -5.5%
Value US$296,185
MATTHEW AHEARN Director; Officer Executive Director
Transaction date
Proposed sale
Price
18.76
Quantity 20,000
Value US$375,200
3.7
Points Jeffrey S. Chief Financial Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 2,000 +2.9%
Value US$30,000
2.5
Buchholz Richard Non-Executive Director
Transaction date
Purchase
Price
14.84
Quantity 1,000 +7.9%
Value US$14,840
2.2
Ball Robert Joseph CEO & Executive Chairman Executive Director
Transaction date
Purchase
Price
15.18
Quantity 2,200 +0.8%
Value US$33,392
2.2
Ball Robert Joseph CEO & Executive Chairman Executive Director
Transaction date
Purchase
Price
14.89
Quantity 3,900 +3.4%
Value US$58,075
3.7
Points Jeffrey S. Chief Financial Officer Officer
Transaction date
Purchase
Price
14.98
Quantity 1,005 +1.9%
Value US$15,055
2.2
Ball Robert Joseph CEO & Executive Chairman Executive Director
Transaction date
Purchase
Price
14.83
Quantity 3,300 +3.0%
Value US$48,934
3.7
Points Jeffrey S. Chief Financial Officer Officer
Transaction date
Purchase
Price
14.65
Quantity 995 +1.9%
Value US$14,577
3.7
Points Jeffrey S. CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
15.67
Quantity 1,600 +3.1%
Value US$25,072
2.2
Ball Robert Joseph CEO & EXECUTIVE CHAIRMAN Executive Director
Transaction date
Purchase
Price
15.49
Quantity 6,000 +5.7%
Value US$92,945
2.2
Ball Robert Joseph CEO & EXECUTIVE CHAIRMAN Executive Director
Transaction date
Purchase
Price
14.90
Quantity 2,000 +1.9%
Value US$29,810
3.7
Points Jeffrey S. CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
15.00
Quantity 50 +inf%
Value US$750
1.6
Carusi Michael A Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 266,666 +16.5%
Value US$3,999,990
1.6
Pardo Geoffrey B Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 100,000 +4.4%
Value US$1,500,000
2.5
Buchholz Richard Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 5,000 +65.2%
Value US$75,000
2.3
Tansey Casey M Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 40,000 +521.8%
Value US$600,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-14 S Sale
2.2
Ball Robert Joseph

CEO & Executive Chairman

Executive Director
3,751 +5.9%
357.28
US$4,400,490 		3,751 +5.9% 357.28 US$4,400,490
2026-09-14 2026-09-14 PrS Proposed sale
2.2
ROBERT BALL

Officer; Director

Executive Director
45,181
494.84
US$2,985,930 		45,181 494.84 US$2,985,930
2026-08-28 2026-08-26 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
4,149 +25.4%
38.96
US$4,191,131 		4,149 +25.4% 38.96 US$4,191,131
2026-08-24 2026-08-24 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
681 -0.0%
22.62
US$15,404 		681 -0.0% 22.62 US$15,404
2026-08-24 2026-08-21 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
20,516 -0.9%
22.61
US$463,867 		20,516 -0.9% 22.61 US$463,867
2026-08-24 2026-08-20 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
3,900 -0.2%
22.60
US$88,140 		3,900 -0.2% 22.60 US$88,140
2026-08-18 2026-08-18 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
1,600 -0.7%
21.38
US$34,211 		1,600 -0.7% 21.38 US$34,211
2026-08-18 2026-08-18 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
12,586 -4.9%
20.94
US$263,493 		12,586 -4.9% 20.94 US$263,493
2026-08-18 2026-08-17 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
8,314 -3.1%
20.10
US$167,101 		8,314 -3.1% 20.10 US$167,101
2026-08-17 2026-08-17 PrS Proposed sale
MATTHEW AHEARN

Director; Officer

Executive Director
22,500
20.73
US$466,425 		22,500 20.73 US$466,425
2026-08-07 2026-08-06 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
2,095 -0.1%
22.60
US$47,347 		2,095 -0.1% 22.60 US$47,347
2026-08-07 2026-08-05 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
7,338 -0.3%
22.64
US$166,132 		7,338 -0.3% 22.64 US$166,132
2026-08-05 2026-08-04 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
99,812 -4.3%
22.77
US$2,272,719 		99,812 -4.3% 22.77 US$2,272,719
2026-08-05 2026-08-03 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
10,751 -0.5%
22.71
US$244,155 		10,751 -0.5% 22.71 US$244,155
2026-08-03 2026-07-31 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
20,034 -0.9%
22.73
US$455,373 		20,034 -0.9% 22.73 US$455,373
2026-08-03 2026-07-30 S Sale
2.7
Gilde Healthcare Holding B.V.
Large shareholder
28,245 -1.2%
23.36
US$659,803 		28,245 -1.2% 23.36 US$659,803
2026-07-29 2026-07-29 PrS Proposed sale
2.7
Gilde Healthcare Holding B.V.; Cooperatieve Gilde Healthcare V U.A.

10% Stockholder

Large shareholder
200,000
24.25
US$4,850,000 		200,000 24.25 US$4,850,000
2026-06-16 2026-06-15 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
2,500 -0.9%
19.26
US$48,148 		2,500 -0.9% 19.26 US$48,148
2026-06-16 2026-06-15 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
1,644 -0.6%
18.20
US$29,922 		1,644 -0.6% 18.20 US$29,922
2026-06-16 2026-06-12 PlS Planned sale
Ahearn Matthew Fraser

Chief Operating Officer

Executive Director
15,856 -5.5%
18.68
US$296,185 		15,856 -5.5% 18.68 US$296,185
2026-06-12 2026-06-12 PrS Proposed sale
MATTHEW AHEARN

Director; Officer

Executive Director
20,000
18.76
US$375,200 		20,000 18.76 US$375,200
2026-03-17 2026-03-13 B Purchase
3.7
Points Jeffrey S.

Chief Financial Officer

Officer
2,000 +2.9%
15.00
US$30,000 		2,000 +2.9% 15.00 US$30,000
2026-03-17 2026-03-13 B Purchase
2.5
Buchholz Richard
Non-Executive Director
1,000 +7.9%
14.84
US$14,840 		1,000 +7.9% 14.84 US$14,840
2026-03-17 2026-03-13 B Purchase
2.2
Ball Robert Joseph

CEO & Executive Chairman

Executive Director
2,200 +0.8%
15.18
US$33,392 		2,200 +0.8% 15.18 US$33,392
2025-12-15 2025-12-12 B Purchase
2.2
Ball Robert Joseph

CEO & Executive Chairman

Executive Director
3,900 +3.4%
14.89
US$58,075 		3,900 +3.4% 14.89 US$58,075
2025-12-15 2025-12-12 B Purchase
3.7
Points Jeffrey S.

Chief Financial Officer

Officer
1,005 +1.9%
14.98
US$15,055 		1,005 +1.9% 14.98 US$15,055
2025-12-15 2025-12-11 B Purchase
2.2
Ball Robert Joseph

CEO & Executive Chairman

Executive Director
3,300 +3.0%
14.83
US$48,934 		3,300 +3.0% 14.83 US$48,934
2025-12-15 2025-12-11 B Purchase
3.7
Points Jeffrey S.

Chief Financial Officer

Officer
995 +1.9%
14.65
US$14,577 		995 +1.9% 14.65 US$14,577
2025-09-15 2025-09-12 B Purchase
3.7
Points Jeffrey S.

CHIEF FINANCIAL OFFICER

Officer
1,600 +3.1%
15.67
US$25,072 		1,600 +3.1% 15.67 US$25,072
2025-09-15 2025-09-12 B Purchase
2.2
Ball Robert Joseph

CEO & EXECUTIVE CHAIRMAN

Executive Director
6,000 +5.7%
15.49
US$92,945 		6,000 +5.7% 15.49 US$92,945
2025-09-15 2025-09-11 B Purchase
2.2
Ball Robert Joseph

CEO & EXECUTIVE CHAIRMAN

Executive Director
2,000 +1.9%
14.90
US$29,810 		2,000 +1.9% 14.90 US$29,810
2025-08-05 2025-08-01 B Purchase
2.7
Gilde Healthcare Holding B.V.
Large shareholder
100,000 +4.4%
15.00
US$1,500,000 		100,000 +4.4% 15.00 US$1,500,000
2025-08-05 2025-08-01 B Purchase
3.7
Points Jeffrey S.

CHIEF FINANCIAL OFFICER

Officer
50 +inf%
15.00
US$750 		50 +inf% 15.00 US$750
2025-08-05 2025-08-01 B Purchase
1.6
Carusi Michael A
Non-Executive Director
266,666 +16.5%
15.00
US$3,999,990 		266,666 +16.5% 15.00 US$3,999,990
2025-08-05 2025-08-01 B Purchase
1.6
LSV Associates II, LLC
266,666 +16.5%
15.00
US$3,999,990 		266,666 +16.5% 15.00 US$3,999,990
2025-08-05 2025-08-01 B Purchase
1.6
Pardo Geoffrey B
Non-Executive Director Large shareholder
100,000 +4.4%
15.00
US$1,500,000 		100,000 +4.4% 15.00 US$1,500,000
2025-08-05 2025-08-01 B Purchase
2.5
Buchholz Richard
Non-Executive Director
5,000 +65.2%
15.00
US$75,000 		5,000 +65.2% 15.00 US$75,000
2025-08-05 2025-08-01 B Purchase
2.3
Tansey Casey M
Non-Executive Director Large shareholder
40,000 +521.8%
15.00
US$600,000 		40,000 +521.8% 15.00 US$600,000
Explore more

More insider trading research around Shoulder Innovations, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America